Evergreen Solar Plans Offering, ThingMagic Teams With Ford, Dynogen Reverse-Merges Onto the Market, & More

Xconomy Boston — 

There used to be a time when almost all the deals in the weekly(ish) roundup involved life sciences companies, but things have been suspiciously quiet on that front in recent weeks. Which is not to say there aren’t plenty of interesting deals to discuss.

—Braving a market that has scared off several local IPOs, Marlboro, MA’s Evergreen Solar (NASDAQ: ESLR) registered for a 20 million-share secondary public offering; the SPO could net the maker of solar-power products some $230 million.

—Waltham, MA’s Liquid Machines, an enterprise rights management firm, raised $10 million in a Series D funding round led by RRE Ventures and joined by return investors Goldman, Sachs & Co.; Atlas Venture; Draper Fisher Jurvetson; and Masthead Ventures.

—Virtualization firm VKernel of Portsmouth, NH, raised $4.6 million in a venture funding round led by Waltham, MA’s Polaris Venture Partners and San Francisco’s Hummer Winblad Venture Partners.

—Dynogen of Waltham, MA, announced that it will go public in a reverse merger with Apex Bioventures Acquisition (AMEX: PEX), a subsidiary of California’s Apex Bioventures set up for the purpose of making just such a deal.

—Cambridge, MA-based ThingMagic teamed up with Ford, lending its RFID technology to the car company’s new tool-tracking trucks.

—Archemix, also of Cambridge, pulled its planned $63 million IPO, citing unfavorable market conditions.

—Boston’s uLocate acquired Cambridge, MA’s Zync, in the midst of a flurry of other location-based company news that Wade wrote up on Friday.

—IDG Ventures Boston and Advanced Technology Ventures led a $25 million Series B financing of Mountain View, CA-based PolyRemedy. The startup plays in the “robotic wound care” space—and Bob explains what that is.

—Waltham, MA vision-correction-technology firm Avedro closed an $8 million Series A-1 funding round led by Prism VentureWorks.

—ByAllAccounts of Woburn, MA, closed a $5 million Series A round led by Commonwealth Capital Ventures.